OTUD5 and lung adenocarcinoma: Additionally, patients with elevated OTUD5 expression had significantly longer overall survival compared to patients bearing tumors that expressed low levels of OTUD5 transcripts in NSCLC (lung adenocarcinoma, LUAD and lung squamous cell carcinoma, LUSC), PADD, CESC, LGG, and BLCA (Fig. 8f).